T1	Participants 48 103	treatment of malignant pleural and pericardial effusion
T2	Participants 260 286	control group, 30 patients
T3	Participants 338 362	N-CWS group, 26 patients
T4	Participants 401 474	in 55 patients with malignant pleural effusion due to primary lung cancer
T5	Participants 753 790	Cardiac tamponade secondary to cancer
T6	Participants 857 1053	Twenty-four patients with malignant pericardial effusion were treated by intrapericardial instillation of anti-cancer drugs, such as Carbazilquinone, Mitomycin-C or ACNU, with pericardial drainage
